| CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives YT Chan, Y Lu, J Wu, C Zhang, HY Tan, Z Bian, N Wang, Y Feng Theranostics 12 (7), 3329, 2022 | 46 | 2022 |
| Multi-component Chinese medicine formulas for drug discovery: state of the art and future perspectives C Zhang, G Chen, G Tang, X Xu, Z Feng, Y Lu, YT Chan, J Wu, Y Chen, ... Acta Materia Medica 2 (1), 106-125, 2023 | 37 | 2023 |
| The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma J Wu, YT Chan, Y Lu, N Wang, Y Feng Medicinal Research Reviews 43 (6), 1946-1973, 2023 | 24 | 2023 |
| Loss of lncRNA LINC01056 leads to sorafenib resistance in HCC YT Chan, J Wu, Y Lu, Q Li, Z Feng, L Xu, H Yuan, T Xing, C Zhang, ... Molecular Cancer 23 (1), 74, 2024 | 19 | 2024 |
| CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress Y Lu, YT Chan, J Wu, Z Feng, H Yuan, Q Li, T Xing, L Xu, C Zhang, ... Drug Resistance Updates 71, 101015, 2023 | 19 | 2023 |
| Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis Y Chan, H Tan, Y Lu, C Zhang, C Cheng, J Wu, N Wang, Y Feng Acta Pharmaceutica Sinica B 13 (4), 1554-1567, 2023 | 19 | 2023 |
| Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma YT Chan, C Zhang, J Wu, P Lu, L Xu, H Yuan, Y Feng, ZS Chen, N Wang Molecular Cancer 23 (1), 189, 2024 | 17 | 2024 |
| Emerging nanomedicine-based therapeutics for hematogenous metastatic cascade inhibition: interfering with the crosstalk between “seed and soil” J Wu, Y Long, M Li, Q He Acta Pharmaceutica Sinica B 11 (8), 2286-2305, 2021 | 16 | 2021 |
| PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer J Wu, HY Tan, YT Chan, Y Lu, Z Feng, H Yuan, C Zhang, Y Feng, N Wang Journal of Experimental & Clinical Cancer Research 43 (1), 42, 2024 | 8 | 2024 |
| Genipin-activating PPARγ impedes CCR2-mediated macrophage infiltration into postoperative liver to suppress recurrence of hepatocellular carcinoma J Wu, YT Chan, Y Lu, Z Feng, H Yuan, X Xu, L Xu, C Zhang, Y Feng, ... International Journal of Biological Sciences 19 (16), 5257, 2023 | 6 | 2023 |
| Traditional Chinese medicine for the treatment of cancers of hepatobiliary system: from clinical evidence to drug discovery J Wu, G Tang, CS Cheng, R Yeerken, YT Chan, Z Fu, YC Zheng, Y Feng, ... Molecular Cancer 23 (1), 218, 2024 | 4 | 2024 |
| Osteoprotegerin mediates adipogenesis in obesity Z Lyu, YT Chan, Y Lu, TF Lam, X Wu, J Wu, L Xu, W Yang, C Zhang, ... Journal of Advanced Research, 2024 | 2 | 2024 |
| Siwu decoction suppress myeloid-derived suppressor cells through tumour cells necroptosis to inhibit hepatocellular carcinoma Z Feng, YT Chan, Y Lu, J Wu, T Xing, H Yuan, Y Feng, N Wang Phytomedicine 133, 155913, 2024 | | 2024 |
Feng YibinProfessor, The University of Hong KongVerifierad e-postadress på hku.hk